Literature DB >> 7499820

Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem.

O Lyytikäinen1, S Köljalg, M Härmä, J Vuopio-Varkila.   

Abstract

Since early 1992 an increased number of tobramycin- and imipenem-resistant Acinetobacter spp. were observed causing colonization, wound infections, and bacteraemias in a burns and plastic surgery unit. This raised the question of whether this outbreak was caused by a single or by multiple Acinetobacter spp. clones. To study this, 97 Acinetobacter spp. isolates from clinical samples from different hospital units as well as isolates from the environment and the hands of the staff were characterized by antibiogram, plasmid profile and ribotyping. Two dominant multi-resistant A. baumannii clones were identified; one of them was sensitive to polymyxin B only. There was a close correlation between the results obtained by plasmid profiling and ribotyping. No common environmental source or significant hand carriage, or spread of these strains outside the unit were detected. The burns patients were the most likely reservoir, and strain transmission occurred in spite of strict control measures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499820     DOI: 10.1016/0195-6701(95)90082-9

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  An array of Escherichia coli clones over-expressing essential proteins: a new strategy of identifying cellular targets of potent antibacterial compounds.

Authors:  H Howard Xu; Lilian Real; Melissa Wu Bailey
Journal:  Biochem Biophys Res Commun       Date:  2006-09-07       Impact factor: 3.575

2.  Molecular typing of Acinetobacter baumannii from ten different intensive care units of a university hospital.

Authors:  E Presterl; R Nadrchal; S Winkler; A Makristathis; W Koller; M L Rotter; A M Hirschl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

3.  Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel.

Authors:  A Simhon; G Rahav; G Shazberg; C Block; H Bercovier; M Shapiro
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii.

Authors:  A Montero; J Ariza; X Corbella; A Doménech; C Cabellos; J Ayats; F Tubau; C Ardanuy; F Gudiol
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.

Authors:  X Corbella; A Montero; M Pujol; M A Domínguez; J Ayats; M J Argerich; F Garrigosa; J Ariza; F Gudiol
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  A review of the Royal Perth Hospital Bali experience: an infection control perspective.

Authors:  Christopher H Heath; C Terri Orrell; Rosie Ce Lee; John W Pearman; Cheryll McCullough; Keryn J Christiansen
Journal:  Aust Infect Control       Date:  2016-03-17

Review 7.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward.

Authors:  Noriyuki Nagano; Yukiko Nagano; Christophe Cordevant; Naohiro Shibata; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.